Announcements
- Fall 2009 Stability Workshop: The AAPS Stability Focus Group has developed
a Stability Workshop for Fall 2009 that will address the role of stability in today’s
increasingly complex pharmaceutical development process and ongoing manufacturing
environment. This workshop will bring together scientists and regulators from around
the world to discuss current requirements, and best practices to address these challenges.
Details to follow once dates/venue confirmed.
- AAPS Webinar Series–Upcoming webinar: "Validating Analytical Methods Based
on Current ICH Guidance and USP/Industry Standards" Friday, February 20,
2009 12:30 PM - 2:00 PM EST (More info)
Stability Focus Group Mission
At the stability testing workshop held November 2005 at the AAPS Annual Meeting
and Exposition in Nashville, TN, discussions were initiated about forming a focus
group to discuss the issues with stability testing and interpretation of new regulatory
guidances. Ideally and globally, we are striving for an understanding, discussion
and solutions to several issues relating to stability testing of API and finished
products. Stability testing is the backbone of drug development and approval, the
product will not be approved without adequate stability information. Issues related
to stability profile of the API or formulated product normally delay product development
as well as regulatory submission.
The goals of this focus group are to:
- establish a core group of interested scientists to explore diverse areas of stability
sciences;
- define technical issues related to stability filing requirements in different climatic
zones;
- provide a forum to discuss stability scientific issues and exchange best practices;
- organize quality programs for the annual meeting and to conduct workshops on current
ICH/FDA and international requirements;
- provide an avenue for training of new guidances on stability related topics; and
- act as a link among members of industry, academy and regulatory.
Stability Focus Group Newsletter
AAPS Stability Focus
Group Survey Results: Input on the Current Practices within the Pharmaceutical and
Biopharmaceutical Industry
Stability-Related Links and Guidance
Voluntary Stability Guidelines—CHPA's Stability Working Group, a subcommittee of
the Manufacturing Controls Committee, is currently active in finalizing the voluntary
stability guidelines published on CHPA's members-only Science & Technology Issues home page. The team is working
to incorporate the comments presented at CHPA's fall Manufacturing Controls Seminar
by FDA's Scott Furness. Furthermore, the team has begun discussions of creating
an impurities guideline for industry. If your company would like a representative
on the Stability Working Group, please contact CHPA's
Rachael Roehrig.
JOIN THE STABILITY FOCUS GROUP
To join the Stability Focus Group, click
here.
Back To Top

Stability Focus Group Past Chair, Kim Huynh-Ba, received the APQ Service Award from
2008 APQ Chair, Vivian Gray
Back To Top
|